Pediatric Graft Versus Host Disease Differential Diagnoses

1. Barnes DW, Loutit JF, Micklem HS. "Secondary disease" of radiation chimeras: a syndrome due to lymphoid aplasia. Ann N Y Acad Sci. 1962 Oct 24. 99:374-85. [QxMD MEDLINE Link].

2. Simonsen M. Graft versus host reactions and their possible implications in man. Bibl Haematol. 1965. 23:115-21. [QxMD MEDLINE Link].

3. Billingham RE. The biology of graft-versus-host reactions. Harvey Lect. 1966. 62:21-78.

4. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991 Mar 7. 324(10):667-74. [QxMD MEDLINE Link].

5. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005 Dec. 11(12):945-56. [QxMD MEDLINE Link].

6. Cho BS, Min CK, Eom KS, et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia. 2008 Oct 2. [QxMD MEDLINE Link].

7. Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone Marrow Transplant. 2008 Jun. 41 Suppl 2:S58-64. [QxMD MEDLINE Link].

8. Sun Y, Tawara I, Toubai T, et al. Pathophysiology of acute graft-versus-host disease: recent advances. Transl Res. 2007 Oct. 150(4):197-214. [QxMD MEDLINE Link].

9. Ferrara JL, Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol. 2006 Jan. 43(1):3-10. [QxMD MEDLINE Link].

10. Stenger EO, Rosborough BR, Mathews LR, Ma H, Mapara MY, Thomson AW, et al. IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-?-Dependent Apoptosis of Alloreactive CD4+ T Cells In Vitro and Reduce Lethal Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2013 Nov 12. [QxMD MEDLINE Link].

11. Ferrara JL, Yanik G. Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies. Clin Adv Hematol Oncol. 2005 May. 3(5):415-9, 428. [QxMD MEDLINE Link].

12. Buxbaum NP, Robinson C, Sinaii N, Ling A, Curtis LM, Pavletic SZ, et al. Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant. 2018 Feb 26. [QxMD MEDLINE Link].

13. Kohler S, Pascher A, Junge G, et al. Graft versus host disease after liver transplantation - a single center experience and review of literature. Transpl Int. 2008 May. 21(5):441-51. [QxMD MEDLINE Link].

14. Kavand S, Lehman JS, Hashmi S, Gibson LE, El-Azhary RA. Cutaneous manifestations of graft-versus-host disease: role of the dermatologist. Int J Dermatol. 2017 Feb. 56 (2):131-140. [QxMD MEDLINE Link].

15. Parkman R. Chronic graft-versus-host disease. Curr Opin Hematol. 1998 Jan. 5(1):22-5. [QxMD MEDLINE Link].

16. Choi SW, Kitko CL, Braun T, et al. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood. 2008 Aug 15. 112(4):1539-42. [QxMD MEDLINE Link].

17. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft versus host disease. Blood. 2008 Oct 2. [QxMD MEDLINE Link].

18. Lubner MG, Menias CO, Agrons M, Alhalabi K, Katabathina VS, Elsayes KM, et al. Imaging of Abdominal and Pelvic Manifestations of Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplant. AJR Am J Roentgenol. 2017 Jul. 209 (1):33-45. [QxMD MEDLINE Link].

19. Antin JH. Approaches to graft-vs-host disease. Pediatr Transplant. 2005 Dec. 9 Suppl 7:71-5. [QxMD MEDLINE Link].

20. Deeg HJ. How I treat refractory acute GVHD. Blood. 2007 May 15. 109(10):4119-26. [QxMD MEDLINE Link].

21. Ferrara JL. Novel strategies for the treatment and diagnosis of graft-versus-host-disease. Best Pract Res Clin Haematol. 2007 Mar. 20(1):91-7. [QxMD MEDLINE Link].

22. Inagaki J, Fukano R, Kodama Y, Nishimura M, Shimokawa M, Okamura J. Safety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation. Ann Hematol. 2013 Oct 22. [QxMD MEDLINE Link].

23. Ussowicz M, Musial J, Mielcarek M, Tomaszewska A, Nasilowska-Adamska B, Kalwak K, et al. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplant Proc. 2013 Nov. 45(9):3375-80. [QxMD MEDLINE Link].

24. Koreth J, Matsuoka K, Kim HT, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011 Dec 1. 365(22):2055-66. [QxMD MEDLINE Link].

25. Shi CR, Huang JT, Nambudiri VE. Pediatric Cutaneous Graft Versus Host Disease: A Review. Curr Pediatr Rev. 2017. 13 (2):100-110. [QxMD MEDLINE Link].

26. Jagasia M, Zeiser R, Arbushites M, Delaite P, Gadbaw B, Bubnoff NV. Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH  trials. Immunotherapy. 2018 Apr. 10 (5):391-402. [QxMD MEDLINE Link]. [Full Text].

27. Lopez F, Parker P, Nademanee A, et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Apr. 11(4):307-13. [QxMD MEDLINE Link].

28. Nick Mulchahy. FDA Approves First-of-Its-Kind Drug for Chronic Graft-Versus-Host Disease. Medscape. Available at https://www.medscape.com/viewarticle/954986. July 29, 2021; Accessed: August 10, 2021.

29. Diaz MA, Vicent MG, Gonzalez ME, et al. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients. Bone Marrow Transplant. 2004 Jul 26. ():[QxMD MEDLINE Link].

30. Faraci M, Dallorso S, Morreale G, et al. Surgery for acute graft-versus-host disease of the bowel: description of a pediatric case. J Pediatr Hematol Oncol. 2004 Jul. 26(7):441-3. [QxMD MEDLINE Link].

31. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am. 1999 Oct. 13(5):1091-112, viii-ix. [QxMD MEDLINE Link].

32. Graubner UB, Liese J, Belohradsky BH. [Vaccination]. Klin Padiatr. 2001 Sep. 213 Suppl 1:A77-83. [QxMD MEDLINE Link].

33. Guinan EC, Bierer BE. Principles of Bone Marrow and Stem Cell Transplantation. Hematology of Infancy and Childhood. 1998. 346-351.

34. Horwitz ME, Sullivan KM. Chronic graft-versus-host disease. Blood Rev. 2006 Jan. 20(1):15-27. [QxMD MEDLINE Link].

35. Klingebiel T, Schlegel PG. GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant. 1998 Apr. 21 Suppl 2:S45-9. [QxMD MEDLINE Link].

36. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001 Oct 1. 98(7):2043-51. [QxMD MEDLINE Link].

37. Lazarus HM, Vogelsang GB, Rowe JM. Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplant. 1997 Mar. 19(6):577-600. [QxMD MEDLINE Link].

38. Messina C, Faraci M, de Fazio V, et al. Prevention and treatment of acute GvHD. Bone Marrow Transplant. 2008 Jun. 41 Suppl 2:S65-70. [QxMD MEDLINE Link].

39. Ringden O, Deeg HJ. Clinical Spectrum of Graft-Versus-Host Disease. 1997. 525-550.

40. Simpson D. New developments in the prophylaxis and treatment of graft versus host disease. Expert Opin Pharmacother. 2001 Jul. 2(7):1109-17. [QxMD MEDLINE Link].

41. Sultan M, Ramprasad J, Jensen MK, Margolis D, Werlin S. Endoscopic diagnosis of pediatric acute gastrointestinal graft-versus-host disease. J Pediatr Gastroenterol Nutr. 2012 Oct. 55(4):417-20. [QxMD MEDLINE Link].

42. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and graft-versus-host disease. Blood. 2005 Jun 1. 105(11):4191-9. [QxMD MEDLINE Link].

Phillip Ruiz, Jr, MD, PhD Professor of Pathology, Department of Pathology and Surgery, Miller School of Medicine, University of Miami

Phillip Ruiz, Jr, MD, PhD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American Society for Clinical Pathology, American Society of Nephrology, American Society of Transplant Surgeons, American Society of Transplantation, Clinical Immunology Society, Florida Medical Association, New York Academy of Sciences, Pan-American Medical Association of Central Florida, Southern Medical Association, United States and Canadian Academy of Pathology

Disclosure: Nothing to disclose.

Shoib Sarwar, MD, MPH Fellowship in Cytopathology and Immunopathology, Department of Pathology, Jackson Memorial Hospital, University of Miami Miller School of Medicine

Shoib Sarwar, MD, MPH is a member of the following medical societies: American Medical Association, American Society for Clinical Pathology, American Society of Cytopathology, College of American Pathologists, United States and Canadian Academy of Pathology, American College of Healthcare Executives

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Harumi Jyonouchi, MD Faculty, Division of Allergy/Immunology and Infectious Diseases, Department of Pediatrics, Saint Peter's University Hospital

Harumi Jyonouchi, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association of Immunologists, American Medical Association, Clinical Immunology Society, New York Academy of Sciences, Society for Experimental Biology and Medicine, Society for Pediatric Research, Society for Mucosal Immunology

Disclosure: Nothing to disclose.

John Wilson Georgitis, MD Consulting Staff, Lafayette Allergy Services

John Wilson Georgitis, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association for the Advancement of Science, American College of Chest Physicians, American Lung Association, American Medical Writers Association, and American Thoracic Society

Disclosure: Nothing to disclose.

Mustafa S Suterwala, MD Pediatrics Hospitalist, Pediatrix Medical Group of North Texas; Medical Director, Tiny Tots Clinic, Baylor University Medical Center

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article